Pregled prema Projekat
European Myeloma Network
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
| 2021 | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S.   ; ...; (broj koautora 23) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2022 | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial | Terpos, Evangelos; ...; Bila, Jelena S. ; ...; (broj koautora 23) | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2023 | Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 21) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |